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Recent studies have shown that STAT3 negatively
regulates the proliferation of muscle satellite cells
(MuSCs) and injury-induced muscle regeneration.
These studies have been largely based on STAT3 in-
hibitors, which may produce off-target effects and
are not cell type-specific in vivo. Here, we examine
the role of STAT3 in MuSCs using two different
mouse models: a MuSC-specific Stat3 knockout
line and a Stat3 (MuSC-specific)/dystrophin (Dmd)
double knockout (dKO) line. Stat3/ MuSCs from
both mutant lines were defective in proliferation.
Moreover, in both mutant strains, the MuSC pool
shrank, and regeneration was compromised after
injury, with defects more pronounced in dKO mice
along with severe muscle inflammation and fibrosis.
We analyzed the transcriptomes of MuSCs from
dKO andDmd/ control mice and identifiedmultiple
STAT3 target genes, including Pax7. Collectively,
our work reveals a critical role of STAT3 in adult
MuSCs that regulates their self-renewal during
injury-induced muscle regeneration.
INTRODUCTION
In vertebrate muscles, muscle satellite cells (MuSCs) are respon-
sible for both embryonic and postnatal muscle growth and mus-
cle regeneration upon injury (Brack and Rando, 2012; Bucking-
ham and Relaix, 2007; Murphy and Kardon, 2011; Scharner
and Zammit, 2011; Yin et al., 2013). Adult MuSCs are quiescent
and characteristically express Pax7, a paired domain- and ho-
meodomain-containing transcription factor (Buckingham and2102 Cell Reports 16, 2102–2115, August 23, 2016 ª 2016 The Autho
This is an open access article under the CC BY-NC-ND license (http://Relaix, 2007; Seale et al., 2000). In addition, the majority of adult
quiescent MuSCs also express Myf5, one of the four genes en-
coding myogenic regulatory factors (MRFs) that also include
MyoD, myogenin, and MRF4 (Beauchamp et al., 2000; Berkes
and Tapscott, 2005; Comai and Tajbakhsh, 2014; Kuang et al.,
2007). Although quiescent MuSCs do not express MyoD, upon
injury, activated MuSCs start to express both Pax7 and MyoD,
re-enter the cell cycle to proliferate, and undergo differentiation
to repair the damaged muscles (Buckingham and Relaix, 2007;
Yin et al., 2013). Some activated MuSCs can self-renew during
regeneration to maintain the MuSC pool (Brack and Rando,
2012; Buckingham and Relaix, 2007; Murphy and Kardon,
2011; Scharner and Zammit, 2011; Yin et al., 2013). Defects in
self-renewal could gradually deplete the stem cell pool and result
in defective tissue regeneration.
The JAK/STAT pathways are activated by a variety of extracel-
lular stimuli, including cytokines and growth factors (Kisseleva
et al., 2002; O’Shea et al., 2002). They are known to regulate
diverse biological processes ranging from immune system
development and inflammation, to embryonic development (Kis-
seleva et al., 2002; O’Shea et al., 2002; Schindler et al., 2007).
Among seven STATs in the mouse genome, only STAT3 is indis-
pensable during embryo development because the germline
Stat3 knockout (KO) leads to embryonic lethality (Takeda et al.,
1997). In myoblasts, we showed previously that a pathway con-
sisting of JAK1, STAT1, and STAT3 potently inhibits myogenic
differentiation in cell culture models in response to leukemia
inhibitory factor (LIF) or Oncostatin M (OSM) (Diao et al., 2009;
Sun et al., 2007; Xiao et al., 2011). In addition, we found that
STAT3 could also promote myoblast differentiation by acting
with JAK2/STAT2 in cell culture (Wang et al., 2008). As for the
in vivo role of STAT3 in adult MuSCs, two recent papers reported
that inhibition of STAT3 in MuSCs by either small interfering
RNAs (siRNAs) or chemical inhibitors enhanced proliferation,
whereas intramuscular injection of STAT3 inhibitors promotedr(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
(legend on next page)
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injury-induced muscle regeneration (Price et al., 2014; Tierney
et al., 2014). However, because Stat3 is ubiquitously expressed,
it is unclear whether the STAT3 inhibitors mainly target MuSC or
other cell types for their pro-regeneration effects. Moreover,
both chemical inhibitors and siRNAs may possess off-target
effects.
To address the in vivo role of STAT3 specifically in adult
MuSCs, we generated two different mouse lines: one with
Stat3 conditionally deleted in MuSCs of otherwise wild-type
(WT) mice and the other in MuSCs from dystrophin (Dmd)-null
mice (i.e., mdx mice), a mouse model for the fatal human
Duchenne muscular dystrophy (Grounds et al., 2008; Willmann
et al., 2009). By analyzing these two mutant lines, we showed
that STAT3 critically regulates MuSC self-renewal during injury-
induced muscle regeneration.
RESULTS
Stat3 Ablation in MuSCs Affected Their Self-Renewal
after Injury
To address the role of STAT3 in adult MuSCs, we first examined
its expression in MuSCs using single myofibers freshly isolated
from wild-type mice either without culturing (to visualize the
quiescent MuSCs) or with 3 days of culturing (to visualize the
activated proliferating MuSCs). Pax7 was used as a marker for
both types of MuSCs. Although the STAT3 protein was present
in both quiescent and proliferating MuSCs (Figure S1A), the tyro-
sine (Y)-705 phosphorylated (i.e., active) STAT3 only appeared in
proliferating MuSCs (Figure S1B). To further reveal the in vivo
function of STAT3 in adult MuSCs, we generated a MuSC-
specific Stat3 KO strain (designated Stat3-cKO) by crossing
Pax7-Cremice with Stat3loxP/loxP mice (Keller et al., 2004; Welte
et al., 2003). Unlike the germline Stat3 KO mice (Takeda et al.,
1997), Stat3-cKO mice were viable and fertile and had no
obvious developmental defects. As expected, the expression
of STAT3 in the mutant mice was greatly diminished only in skel-
etal muscles but not in the heart or brain tissues (Figure S2A). We
then quantified the number of Pax7+ adult quiescent MuSCs
using either isolated single myofibers (Figures S2B and S2C) or
cryosections of the tibialis anterior (TA) muscles (Figures S2D
and S2E). No significant difference was found between Stat3-
cKO and wild-type control mice. To assess the regenerative abil-
ity of Stat3/ MuSC in vivo, we employed cardiotoxin (CTX)-
inducedmuscle regeneration assays and assessed regeneration
on days 3, 5, and 7 after injury (Charge´ and Rudnicki, 2004; Fig-
ure S2F). Only on day 5 after injury did we observe a mild delay inFigure 1. Defective Self-Renewal of the Stat3/ MuSC Pool after Injur
(A) Four weeks after the first CTX injury, TA sections were subjected to immunos
(B) Quantification of the Pax7+ MuSC on TA sections from (A). The average numb
three pairs of WT and Stat3-cKO mice are shown. The results are presented as m
(C) Schematic of the experimental design for (D).
(D) Regenerating TA sections from WT and Stat3-cKO mice were examined by b
(E) Quantification of eMHC+ fibers. The percentage of eMHC+ fibers over total fib
mice.
(F) Quantification of the cross-section area (CSA) of individual myofibers in (D) usi
the total myofibers was calculated for each mouse. About 600 myofibers from fou
**p < 0.01, ***p < 0.001, ****p < 0.0001.
Scale bars, 100 and 200 mm in (A) and (D), respectively. See also Figures S1–S3
2104 Cell Reports 16, 2102–2115, August 23, 2016regeneration in Stat3-cKO mice, as evidenced by the presence
of fewer newly regenerated myofibers (i.e., those with centrally
localized nuclei) per microscopic field, more degenerating fibers
in the injury center, and more embryonic myosin heavy chain-
expressing (eMHC, a marker transiently expressed in early re-
generating myofibers) fibers in the surrounding areas (Figures
S2G–S2K; d’Albis et al., 1988).
To assesswhether STAT3 regulatesMuSC self-renewal during
regeneration, we examined the number of Pax7+ MuSCs in both
wild-type and Stat3-cKOmice 4 weeks after CTX-induced injury.
By then, nearly all Pax7+ MuSCs had already returned to the
quiescent state, as evidenced by the predominant presence of
Pax7+/Ki67 cells (Ki67 was used here as a marker for prolifer-
ating cells) (Figures S3A and S3B). Notably, there was an
50% reduction in the number of Pax7+ quiescent MuSCs on
muscle sections from Stat3-cKO mice (Figures 1A and 1B).
With fewer MuSCs, we expected poorer regeneration when the
newly-regenerated muscle was injured again in Stat3-cKO
mice. To test this hypothesis, we adopted a regeneration proto-
col with sequential injuries (Figure 1C). Seven days after the sec-
ond CTX injury, there was indeed a more severe regeneration
defect in Stat3-cKOmice, as evidenced by the larger unrepaired
area in the injury center and more eMHC+ myofibers in the sur-
rounding areas (Figures 1D and 1E). Moreover, in areas where
regeneration was completed, the size (i.e., cross-section area)
of the newly regenerated myofibers (i.e., those marked by lami-
nin staining with centrally localized nuclei) was generally smaller
in Stat3-cKOmice (Figures 1D and 1F). Nevertheless, by 30 days
after the second injury (Figure S3C), the injured muscles from
Stat3-cKO mice were completely regenerated, but the number
of quiescent Pax7+ MuSCs remained low compared with that
of wild-type mice (Figures S3D and S3E). Our data indicated
that Stat3 ablation in MuSCs impairs their self-renewal after
muscle injury.
Stat3 Ablation in MuSCs of Dystrophic Mice Led to
Severe Muscle Defects
To study the effect of Stat3 in MuSCs of chronic dystrophic mus-
cles, we crossed Stat3-cKO mice with mdx mice to generate
Stat3 (MuSC-specific)/Dmd double knockout (dKO) mice. Mdx
mice are widely used as a dystrophic mouse model for the fatal
human Duchenne muscular dystrophy (DMD) (Grounds et al.,
2008; Willmann et al., 2009). The muscles of mdx mice undergo
repeated cycles of degeneration and regeneration starting
around 3 weeks of age (Grounds et al., 2008; Willmann et al.,
2009). Notably, before the muscle degeneration cycles started,y
taining for Pax7 and laminin. The nuclei were counterstained with DAPI.
ers of Pax7+ MuSC/100 myofibers on 30 TA sections (5 sections/mouse) from
ean ± SEM. **p < 0.01.
oth H&E staining and immunostaining.
ers was calculated using multiple TA sections from three pairs of WT and cKO
ng MetaMorph. The percentage of myofibers with a defined range of CSA over
r pairs of littermates were counted. The results are presented as mean ± SEM.
.
Figure 2. dKO Mice Displayed Severe Muscle Defects with Enhanced Inflammation, Fibrosis, and Fat Deposition
(A–D) TAmuscle sections from 6-, 8-, and 20-week-oldmdx and dKOmice were subjected to trichrome staining (A) or immunostaining for CD68 (C). The extent of
fibrosis and inflammation in (A) and (C) is quantified in (B) and (D), respectively. MFI, mean fluorescence intensity.
(E–H) Gastrocnemius muscle sections from 60-week-old mdx and dKO mice were subjected to trichrome (E) or oil red O staining (G). The areas positive for
collagen and oil red O staining are quantified in (F) and (H), respectively.
In (B), (D), (F), and (H), multiple sections from three pairs ofmdx and dKOmice were examined and analyzed by NIS-Elements (Nikon). The data are presented as
mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bars, 200 mm. See also Figure S4.the body size, weight, and number of Pax7+MuSCs was compa-
rable between dKO mice and their mdx controls (Figures S4A–
S4D). However, dKO mice started to show obvious growth
defects about 4 weeks after birth; they were smaller in size and
lighter in body weight (Figure S4A). Between 10-12 months
of age,most dKOmice displayed kyphosis anddied (Figure S4E).
Consistently, different muscles dissected from 10- to 12-month-
old dKO mice were also smaller than those of their mdx litter-mates (Figure S4F). When we subjected TA muscle sections
from 6-, 8-, and 20-week-oldmdx and dKOmice to H&E staining,
muscles of dKOmice showed increased age-dependent signs of
fibrosis (Figure S4G), which was further confirmed by Masson’s
trichrome staining, which directly detects collagen deposition
(blue) on muscle sections (Figures 2A and 2B). In addition, we
also detected enhanced infiltration of CD68+ macrophages on
TA sections from dKO mice (Figures 2C and 2D), indicative ofCell Reports 16, 2102–2115, August 23, 2016 2105
enhanced inflammation in muscles of dKO mice. Surprisingly, in
gastrocnemius muscles from 60-week-old dKO mice, the myo-
fibers were almost completely replaced by fibrotic tissues (Fig-
ures 2E and 2F). Moreover, we also detected increased fat depo-
sition on muscle sections from 60-week-old dKO mice (Figures
2G and 2H).
Adult dKO Mice Displayed a Gradual Reduction in the
Number of Pax7+ MuSCs
Because muscles of adult mdx mice undergo repeated cycles
of degeneration and regeneration, it is crucial for mdx mice to
maintain a constant pool of Pax7+ MuSCs. In TA muscles from
6-week-old mdx and dKO mice, the number of Pax7+ MuSCs
from dKO mice was about 50% of that from mdx mice of the
same litters (Figures 3A and 3B). In TA muscles from 8- and
20-week-old dKO mice, the number of Pax7+ MuSCs dropped
further to about 20% of that from mdx mice of the same litters
(Figures 3C–3F). These data indicated that, unlike their mdx
counterparts, dKO mice were defective in MuSC self-renewal
with chronic muscle injury.
Stat3/ MuSCs Were Defective in Cell Proliferation
The decrease in MuSC number in our Stat3-null mice was unex-
pected considering recent findings of increased MuSC prolifera-
tion after transient inhibition of STAT3 by chemical inhibitors or
siRNAs (Price et al., 2014; Tierney et al., 2014). To further reveal
the proliferation potentials of Stat3/ MuSCs, we first isolated
MuSCs by fluorescence-activated cell sorting (FACS) and
examined their proliferation potentials in culture by 5-ethynyl-
2’-deoxyuridine (EdU) incorporation assays. Compared with
the controls, Stat3/ MuSCs had a reduced EdU incorporation
rate (Figures 4A and 4B). Consistently, when we isolated single
myofibers and placed them in culture, fewer Pax7+/MyoD+ (i.e.,
transit-amplifying cells) were present on myofibers from Stat3-
cKO mice (Figures 4C and 4D). Similarly, decreased EdU incor-
poration was also seen in MuSCs from dKOmice compared with
that from the mdx controls (Figures 4E and 4F). Furthermore,
fewer Pax7+/MyoD+ cells were present in MuSC freshly isolated
from dKO mice without culturing (Figures 4G and 4H). Collec-
tively, our data above revealed that Stat3/MuSCwere intrinsi-
cally defective in cell proliferation.
Loss of Stat3 in Dmd/ MuSCs Dysregulated Genes
Involved in the Regulation of MuSC Proliferation and
Maintenance
To reveal the underlying mechanisms responsible for defective
MuSCs in dKO mice, we isolated MuSCs by FACS from both
dKO mice and mdx controls, examined their transcriptome pro-
files by RNA sequencing (RNA-seq), and identified differentially
expressed genes in dKO mice (Table 1). To validate the RNA-
seq data, changes in selected genes were further confirmed by
qRT-PCR using an independent batch of MuSCs from mdx
and dKO mice (Figure S5A). Because the comparison was
made between mdx and dKO mice (the only difference between
them is the presence or absence of Stat3 in MuSCs), the altered
expression of those genes in dKOmice was obviously due to the
loss ofStat3. However, it was unclear whether loss ofStat3 alone
was sufficient to cause all the changes. To address this issue, we2106 Cell Reports 16, 2102–2115, August 23, 2016selected some genes from Table 1 and examined their expres-
sion by qRT-PCR in FACS-isolated MuSCs from Stat3-cKO
mice and wild-type controls. We found that some genes (like
Pax7, MyoD, Igf2bp2, and Cxcl10) were indeed affected by
loss of Stat3 alone in response to CTX-induced injury, whereas
others (like Col1a1 and Fn1) were not, suggesting that additional
factors were needed to cooperate with STAT3 (Figure S5B).
Among STAT3 target genes, several known MuSC-related
genes, including Pax7,MyoD, Igf2bp2, and Hmga1, were down-
regulated in dKO mice (Figure 5; Figures S5C–S5F). As ex-
pected, Stat3 itself was downregulated in MuSC from dKO
mice (Figures 5A and 5B). The relatively high FPKM (i.e., frag-
ments per kilobase of transcript per million mapped reads) value
forStat3 in dKOmice (Table 1) was due to the presence of mRNA
transcribed from the remaining exons after Cre-mediated
recombination. Few sequences were identified from the Stat3
exons flanked by loxP sites inMuSCs from dKOmice (Figure 5A).
Consistent with a recent report (Tierney et al., 2014), MyoD was
also found to be downregulated in ourStat3/MuSCs. For Pax7
(Figures 5C and 5D), it is known to be essential for both prolifer-
ation and maintenance of MuSCs (Diao et al., 2012; G€unther
et al., 2013; vonMaltzahn et al., 2013). Our bioinformatic analysis
revealed the existence of three potential STAT3 binding sites in
the proximal promoter (i.e.,2 kb to +1 kb) of thePax7 gene (Fig-
ure 5E). To test whether STAT3 actually binds to these sites in
MuSCs, we isolated GFP+ MuSCs by FACS using a transgenic
(Tg) mouse line (i.e., Tg: Pax7-nGFP) that specifically expresses
a nuclear GFP in MuSCs (Sambasivan et al., 2009). We then per-
formed chromatin immunoprecipitation (ChIP) assays for STAT3
and found that there was an obvious enrichment of STAT3 at site
3 in the Pax7 promoter (Figure 5F). For Igf2bp2 and Hmga1, a
recent study showed that Igf2bp2 and Hmga2 (a homolog of
Hmga1) are expressed in MuSCs and required for their prolifer-
ation (Li et al., 2012). To assess the functional consequence of
their downregulation, we knocked down Igf2bp2 and Hmga1
individually by siRNA in C2C12 myoblasts and found that down-
regulation of either gene enhanced the expression ofmyogenin,
a member of the MRFs that is normally induced only in differen-
tiating myocytes and differentiated myotubes (Figures S5G and
S5H; Puri and Sartorelli, 2000; Sabourin and Rudnicki, 2000).
As for Pax7, induction of myogenin expression was also seen
when Pax7 was knocked down in MuSCs (G€unther et al., 2013;
von Maltzahn et al., 2013). Consistently, when we placed
FACS-isolated MuSCs or single myofibers in culture, more myo-
genin+ or MHC+ cells were found in MuSCs or on myofibers from
Stat3-cKO mice (Figures S6A–S6G). Similarly, more myogenin+
cells were found in cultured MuSCs from dKOmice than in those
from mdx controls (Figures S6H and S6I). Collectively, our data
above show that loss of Stat3 in MuSCs downregulates Pax7,
Igf2bp2, and Hmga1, which collectively promotes precocious
differentiation of MuSCs.
Loss of Stat3 in Dmd/MuSCs Induced the Expression
of Many Pro-inflammatory Cytokine and Chemokine
Genes
Among genes that were upregulated in dKO mice, one group
was related to pro-inflammatory cytokines (e.g., Il-6, Il-33) and
chemokines (Ccl2, Ccl5, Ccl7, Cxcl1, Cxcl2, Cxcl3, Cxcl10)
(legend on next page)
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(Table 1; Figure 6A). To further understand the functional signif-
icance of such gene induction, we focused on CCL2 and CCL7,
which are known to trigger macrophage infiltration from the
blood to inflamed tissues (Shi and Pamer, 2011; Tsou et al.,
2007). To examine their roles in vivo, we generated two expres-
sion vectors encoding the full-length (including the signal
peptide) CCL2 and CCL7, respectively. The control (i.e., GFP-
expressing) and CCL2-expressing or CCL7-expressing DNA
constructs were separately electroporated into TA muscles in
both legs of adult mice. Three days after electroporation, by
H&E staining or immunostaining, we could readily observe
massive infiltration of inflammatory cells or CD68+ macrophages
only in muscles electroporated with CCL2- or CCL7-expressing
vector but not in contralateral TA muscles overexpressing GFP
(Figure 6B). Our data suggest that induction of pro-inflammatory
cytokines and chemokines in Stat3/ MuSCs contributes to
enhanced muscle inflammation in dKO mice.
Loss of Stat3 in Dmd/MuSCs Induced the Expression
of Multiple Pro-fibrotic Genes
In addition to pro-inflammatory cytokine and chemokine
genes, a group of fibrosis-related genes, including those that
encode collagens and extracellular matrix (ECM) components,
were also upregulated in MuSCs from dKO mice (Table 1; Fig-
ure 6C). By immunostaining, we confirmed that MuSCs from
dKO mice indeed expressed more collagen 1 protein than those
from mdx mice (Figures 6D and 6E). In muscle fibrosis, major
cellular players are platelet-derived growth factor receptor alpha
(PDGFRa)-expressing fibroadipogenic progenitor cells (FAPs)
(Joe et al., 2010; Lemos et al., 2015; Uezumi et al., 2010). In
our FACS scheme for MuSC isolation, a population of CD31/
CD45/Sca1+ cells (depicted in blue) represents such FAPs (Fig-
ure 6F) because they were mostly PDGFRa+ and could differen-
tiate into both smooth muscle actin-positive fibroblasts and lipid
droplet-containing adipocytes in culture (Figures 6G and 6H;
H.Z., unpublished data; Joe et al., 2010). Interestingly, we found
that the percentage of FAPs in dKO mice was nearly doubled
compared with that in mdx controls, concomitant with a reduc-
tion in the percentage of MuSCs in dKO mice (Figure 6F). Our
data showed that loss ofStat3 inDmd/MuSCnot only induced
expression of multiple pro-fibrotic genes in MuSCs but also
increased the population of FAPs in muscles, which collectively
contributes to enhanced fibrosis in dKO mice.
DISCUSSION
STAT3 is known to function in different types of stem cells. In
mouse embryonic stem cells (ESCs), STAT3 serves as a key
mediator downstream of leukemia inhibitory factor to promote
self-renewal and to help maintain the pluripotency of ESCs
(Nichols and Smith, 2009). In small intestine stem cells, STAT3Figure 3. Defective Self-Renewal of MuSCs in dKO Mice
(A, C, and E) TA sections from 6- (A), 8- (C), and 20-week-old (E) mdx and dKO m
counterstained with DAPI. The images are representative multiple sections from
(B, D, and F) Quantification of Pax7+ cell number/100 myofibers from TA sections
from three pairs of mdx and dKO mice of the same litters, and the results are pre
**p < 0.01, ***p < 0.001.
2108 Cell Reports 16, 2102–2115, August 23, 2016is essential for stem cell survival (Matthews et al., 2011). In he-
matopoietic stem cells, STAT3 promotes their self-renewal
(Chung et al., 2006; Mantel et al., 2012). In the subgranular
zone of the adult dentate gyrus, STAT3 is required for the prolif-
eration and maintenance of the neural stem cell pool (M€uller
et al., 2009). Our current study reveals that Stat3 deletion in
Pax7+ muscle progenitor cells does not affect normal muscle
development and the establishment of the adult quiescent
MuSC pool but impairs MuSC self-renewal upon muscle injury.
We show that Stat3/ MuSC have defective proliferation but
increased propensity for precocious differentiation, which could
result from downregulation of several key STAT3 target genes,
including Pax7, Igf2bp2, and Hmga1. For Pax7, we showed
that it is a direct target of STAT3 in MuSCs (Figure 5). Loss or
downregulation of Pax7 is known to not only severely compro-
mise MuSC proliferation but also promote their precocious
differentiation (G€unther et al., 2013; Kuang et al., 2006; vonMalt-
zahn et al., 2013; Oustanina et al., 2004; Relaix et al., 2006).
Moreover, reduced Pax7 expression in Stat3/ MuSCs could
also compromise their ability to return to the quiescent state
during regeneration because elevated Pax7 expression is
needed in this process (Mourikis and Tajbakhsh, 2014). In addi-
tion, MyoD was also found to be a target of STAT3 in our study
(Table 1; Figure S5B) and by Tierney et al. (2014). Unlike
MyoD/MuSCs, which are defective inmyogenic differentiation
(Sabourin et al., 1999; Yablonka-Reuveni et al., 1999), Stat3/
MuSCs with 40% reduction in their MyoD levels undergo pre-
cocious differentiation (Figure S6). It is likely that downregulation
of other key STAT3 target genes, especially Pax7, has a more
dominant effect on MuSCs. Moreover, both Myf5 and the re-
mainingMyoD in Stat3/MuSCs may be sufficient to drive pre-
cocious differentiation.
Two recent papers also studied the role of STAT3 in adult
MuSCs (Price et al., 2014; Tierney et al., 2014). Both mainly em-
ployed the approaches of transient STAT3 inhibition by chemical
inhibitors or siRNAs, which was found to enhance MuSC prolif-
eration. However, a consistent decrease in MuSC proliferation
and self-renewal was seen in both ourStat3mutant lines (Figures
1B, 3, and 4). Moreover, both papers found that intramuscular
injection of STAT3 inhibitors improved muscle regeneration in
either normal or dystrophic mice, which again differed from
the findings from our Stat3 KO mice. We think that different ap-
proaches that are used to inactivate STAT3 (i.e., permanent ge-
netic deletion versus transient inhibition by chemical inhibitors or
siRNA) underlie the differences between our results and those
in the two papers. In support of this notion, when an inducible
Stat3 KOmouse model was used to assess injury-induced mus-
cle regeneration, a similar finding (i.e., defective regeneration) as
that from our Stat3-cKOmice was obtained (Tierney et al., 2014).
Our Stat3 KO mice-derived data suggest that continuous long-
term inhibition of STAT3 by chemical inhibitors is undesirableice were subjected to immunostaining for Pax7 and laminin. The nuclei were
three pairs of littermates. Scale bars, 100 mm.
in (A), (C), and (E). The number of Pax7+MuSCs was counted on 30 TA sections
sented as mean ± SEM.
Figure 4. Stat3/ MuSCs Were Defective in Cell Proliferation
(A) An equal number of FACS-isolated MuSCs fromWT and Stat3-cKOmice was placed in culture in triplicate for 2 days, followed by EdU labeling for 4 hr before
cell fixation and immunostaining for EdU. Nuclei were counterstained with DAPI.
(B) Quantification of the percentage of EdU+ cells in (A).
(C) Single myofibers from WT and Stat3-cKO mice were placed in culture for 2 days, followed by immunostaining for Pax7 and MyoD.
(D) Quantification of Pax7+/MyoD+ cells on single myofibers in (C). 25 single fibers from three pairs of WT and cKO mice were examined. Each dot represents
a fiber.
(E) As in (A), FACS-isolated MuSC from mdx and dKO mice were subjected to EdU labeling assays.
(F) Quantification of the percentage of EdU+ cells as in (B).
(legend continued on next page)
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Table 1. List of Selected Differentially Expressed Genes in









Change p Value q Value
Genes Upregulated
Il6 11.5 25.6 2.2 0.00015 0.0091
Il33 6.4 24.9 3.9 5.00E05 0.0032
Ccl2 137.5 248.7 1.8 5.00E05 0.0032
Ccl5 9.6 49.6 5.1 5.00E05 0.0032
Ccl7 75.4 152.7 2.0 5.00E05 0.0032
Cxcl1 667.5 1357.7 2.0 5.00E05 0.0032
Cxcl2 14.1 37.6 2.6 5.00E05 0.0032
Cxcl3 4.7 13.6 2.9 0.00035 0.0200
Cxcl10 16.3 43.9 2.7 0.0002 0.0118
Stat1 4.8 10.4 2.2 0.0003 0.0173
Col1a1 36.7 93.5 2.5 0.0008 0.0415
Col4a1 103.7 209.6 2.0 5.00E05 0.0032
Col4a2 71.2 165.3 2.3 5.00E05 0.0032
Col5a3 55.3 101.9 1.8 5.00E05 0.0032
Col6a2 11.3 25.0 2.2 5.00E05 0.0032
Col15a1 7.3 13.6 1.9 0.0002 0.0118
Itgb2 1.2 6.9 5.9 0.00045 0.0251
Itga5 37.9 63.3 1.7 0.0002 0.0118
Fn1 35.1 76.5 2.2 5.00E05 0.0032
Dcn 46.4 82.7 1.8 5.00E05 0.0032
Timp3 35.6 63.0 1.8 5.00E05 0.0032
Mmp12 1.3 4.4 3.4 5.00E05 0.0032
Genes Downregulated
Pax7 34.4 18.4 0.5 0.00015 0.0091
MyoD 135.2 56.5 0.4 5.00E05 0.0032
Igf2bp2 52.7 11.3 0.2 5.00E05 0.0032
Hmga1 68.9 28.9 0.4 5.00E05 0.0032
Stat3 149.2 40.1 0.3 5.00E05 0.0032
Osmr 109.3 10.2 0.1 5.00E05 0.0032
FACS-isolatedMuSCs from three pairs ofmdx and dKOmice of the same
litters were subjected to RNA-seq. Genes are represented by official gene
symbols. The mean FPKM values for selected genes are indicated. The
data were analyzed by Cuffdiff 2, and both the p values and q values
from the statistical analysis are shown.for future clinical treatment of DMD patients because it could
further impair the regeneration process over time due to gradual
depletion of MuSCs. However, based on the two published re-
ports, ‘‘transient and periodic’’ treatment of dystrophic or aged
muscles with a STAT3 inhibitor may offer some beneficial ef-
fects, which is likely due to reduced STAT3 activity in other cell
types (e.g., inflammatory macrophages) in the MuSC niche.(G)MuSC freshly isolated frommdx and dKOmicewithout culturing were subjecte
white arrowheads.
(H) Quantification of Pax7+/MyoD+ cells over total DAPI+ cells as in (B).
About 1,200 cells from three pairs of control andStat3/micewere examined in (B
in (H). The experiment in (G) was repeated once with similar results. The data are
2110 Cell Reports 16, 2102–2115, August 23, 2016Although our constitutive Pax7-Cre-mediated Stat3 deletion re-
sults inStat3 ablation in bothMuSCs andmyofibers (Figure S2A),
the regeneration defects in our Stat3 KO mice are most likely
caused by the loss of Stat3 in MuSCs because of their indispens-
able roles in regeneration. The reduced proliferation and preco-
cious differentiation seen in FACS-isolated Stat3/ MuSCs in
culture further point to intrinsic defects in such cells. Neverthe-
less, our data do not completely rule out a possible role of
Stat3 in myofibers during muscle regeneration because myofib-
ers constitute an integral part of the MuSC niche.
During muscle regeneration, MuSCs also need help from sur-
rounding niche cells, including the muscle-resident FAPs and
infiltrating inflammatory cells (Arnold et al., 2007; Heredia et al.,
2013; Joe et al., 2010; Uezumi et al., 2010). In particular, macro-
phages were shown to be indispensable for efficient muscle
regeneration (Arnold et al., 2007; Saclier et al., 2013). As for
the cellular source of chemokines that recruit circulating macro-
phages/monocytes to the injured sites, an earlier study using
in vitro myoblast/macrophage co-culture systems revealed
that human primary myoblasts express Ccl2 and Cx3cl1 and
promote macrophage chemotaxis (Chazaud et al., 2003). Simi-
larly, many chemokine and cytokine genes were also found to
be expressed in cultured mouse primary myoblasts (Griffin
et al., 2010). Here we directly analyzed MuSCs freshly isolated
from mdx or dKO mice by FACS without any in vitro culturing.
Our RNA-seq data both confirmed and further extended the pre-
vious findings by showing that many pro-inflammatory cytokine
(e.g., Il-6, Il-33) and chemokine (e.g., Ccl2, Ccl7) genes were up-
regulated in MuSCs from dKOmice (Table 1; Figures 6A and 6B).
Mechanistically, STAT3 is known to have anti-inflammatory
functions in vivo by mediating the action of IL-10 (Hutchins
et al., 2013; Regis et al., 2008). Loss of Stat3 not only reduces
the expression of many anti-inflammatory genes but also pro-
motes the STAT1-dependent pro-inflammatory response (Regis
et al., 2008). Consistently, we observed elevated expression of
both Stat1 and some STAT1-dependent genes (e.g., Cxcl10
and Ccl5) in MuSCs from dKO mice. Among the upregulated
chemokine genes, both Ccl2 and Ccl7 encode potent chemoat-
tractants for recruitment of CCR2+ inflammatory macrophages
from blood into the sites of inflammation in tissues (Shi and
Pamer, 2011; Tsou et al., 2007). Using both Ccl2 and Ccr2 KO
mice, several groups have also demonstrated an important
role for Ccl2 and Ccr2 in macrophage recruitment during
injury-induced muscle regeneration (Lu et al., 2011a, 2011b;
Shireman et al., 2007; Warren et al., 2005). In support of those
loss-of-function data, we found that ectopic expression of either
CCL2 or CCL7 alone in uninjured TA muscles was already suffi-
cient to trigger massive infiltration of CD68+ macrophages into
muscles (Figure 6B). Thus, our data not only provide definitive
evidence showing that activated MuSCs can serve as a source
of chemokines to recruit circulating macrophages but also help
explain why there is enhanced inflammation in dKO mice.d to immunostaining for Pax7 andMyoD. The Pax7+/MyoD+ cells aremarked by
) and (F), whereas 400 cells from one pair ofmdx and dKOmicewere examined
presented as mean ± SEM. *p < 0.05; **p < 0.01. Scale bars, 100 mm.
Figure 5. STAT3 Directly Binds to the Pax7 Promoter in MuSCs
(A–D) Representative RNA-seq profiles at theStat3 (A) andPax7 (C) loci inMuSCs frommdx and dKOmice. The exons boxed in red at theStat3 locuswere flanked
by loxP and deleted in dKOmice. Bar plots represent themean FPKM values forStat3 (B) andPax7 (D) inMuSCs from three pairs ofmdx and dKOmice. Error bars
were calculated by Cuffdiff 2.
(E) Schematic of the Pax7 promoter near the transcription start site (TSS) with three predicted STAT3 binding sites (i.e., B1–3) by PROMO.
(F) STAT3 ChIP assays using FACS-isolated GFP+ MuSCs. qPCR was performed in quadruplicate. Fold enrichment was calculated as the ratio of the relative
amount of DNA immunoprecipitated by the STAT3 antibody over that by control immunoglobulin G (IgG).
The data are presented as mean ± SEM. **p < 0.01, ***p < 0.001. N.S., not significant; R1, a non-relevant control site on a different gene. See also Figures S5
and S6.Muscle fibrosis is another disease hallmark in late-stage
DMD patients and is characterized by enhanced expression
and deposition of ECM proteins, with collagen (especially types
I and III) being the most abundant ECM component (Mann et al.,
2011; Wynn, 2008). Other common ECM proteins also include
fibronectin (Fn1), decorin (Dcn), elastin, and laminin. Although
mdx mice partially recapitulate certain disease phenotypes
seen in human DMD patients, the pathological symptoms,
including muscle fibrosis, are generally much less severe
in mdx mice (Grounds et al., 2008; Willmann et al., 2009).
Moreover, unlike DMD patients who usually die in their early
twenties, mdx mice have a near-normal lifespan (Grounds
et al., 2008;Willmann et al., 2009). Notably, our dKOmice display
severe muscle fibrosis with increased age and die prematurelybetween 10–12 months of age, suggesting that they can serve
as a better model for human DMD. The cellular source for ECM
protein production during muscle fibrosis includes muscle-resi-
dent FAPs (Lemos et al., 2015; Mann et al., 2011). In addition,
both immortalized and primary myoblasts cultured in vitro
were also shown to produce type I and III collagens (Alexakis
et al., 2007). Here, using MuSCs freshly sorted from muscles,
we confirmed that MuSCs of mdx mice indeed express multiple
pro-fibrotic genes. Importantly, loss of Stat3 in MuSCs of dystro-
phic muscles further enhanced the expression of such genes. In
addition, several pro-inflammatory cytokines (e.g., interleukin-6
[IL-6]) and chemokines (e.g., CCL2) that were upregulated in
MuSCs from dKO mice are also known to actively promote
fibrosis (Wynn, 2008). Consistently, by a genetic lineage-tracingCell Reports 16, 2102–2115, August 23, 2016 2111
Figure 6. Multiple Pro-inflammatory and Pro-fibrotic Genes Were Induced in dKO Mice
(A) Gene expression heatmap based on gene set enrichment analysis (GSEA) revealed enrichment of genes of the ‘‘chemokine signaling pathways’’ in MuSCs
from dKO mice. Different colors (red, pink, light blue, and dark blue) represent different expression levels (high, moderate, low, and lowest, respectively).
(B) TA muscles of adult WT mice were electroporated with a CCL2- or CCL7-expressing vector in one leg and a GFP-expressing vector (control) in the
contralateral leg. Three days later, TA muscle sections were subjected to H&E staining (top) or immunostaining for CD68 (bottom).
(C) Gene expression heat map as in (A) showing the enrichment of genes of the ‘‘ECM receptor interaction’’ in MuSCs from dKO mice.
(D) FACS-isolated MuSCs from 20-week-old mdx and dKO mice were cultured overnight, followed by co-staining for collagen 1 (green) and Pax7 (red). Nuclei
were counterstained with DAPI (blue).
(E) Quantification of collagen 1+ cells in Pax7+ MuSCs from mdx and dKO mice in (D). About 1,200 cells from three pairs of mdx and dKO mice were used for
quantification.
(F) Representative FACS plots. About 100,000 cells from three pairs of 20-week-old mdx and dKO mice were sorted by FACS. The percentage of MuSCs and
FAPs was calculated.
(G andH) The CD31/CD45/Sca1+ cells from threemdxmice in (F) were further sorted based on the presence of PDGFRa (G) or seeded in culture and stained for
PDGFRa (H).
In (E) and (F), the data are presented as mean ± SEM. **p < 0.01, ****p < 0.0001. In (H), 200 cells from five randomly chosen fields were examined. Scale bars,
100 mm in (B) and (H) and 50 mm in (D).
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technique, a recent report also demonstrated that a subset of
MuSCs from aged mdx mice express many pro-fibrotic genes,
including Col1a1 and Fn1,with simultaneous loss of expression
ofmyogenic genes (e.g.,Pax7,MyoD) (Biressi et al., 2014).More-
over, an earlier study found that aged cardiac-specific Stat3 KO
mice also displayed enhanced cardiac fibrosis (Jacoby et al.,
2003). In both cases, fibrosis becomes more obvious in aged
Stat3 mutant mice, suggesting that additional age-related fac-
tors are involved in this process.
In summary, our work here has revealed a previously unrecog-
nized but important role for STAT3 in regulating adult MuSC
self-renewal during both acute and chronic muscle injuries. In
dystrophic muscles, as loss of Stat3 leads to gradual depletion
of MuSC accompanied with aggravated muscle inflammation
and fibrosis, therapeutic strategies that involve deliberate
STAT3 activation in MuSC may alleviate the disease symptoms.
EXPERIMENTAL PROCEDURES
Animals
C57BL/6 and mdx mice were from The Jackson Laboratory. Stat3loxP/loxP,
Pax7-Cre and Tg: Pax7-nGFP mice were kindly provided by Drs. X.Y. Fu (Na-
tional University of Singapore [NUS]), M.R. Capecchi (University of Utah), and
S. Tajbakhsh (Institut Pasteur), respectively. The Stat3 conditional KO strain
(Stat3-cKO: Stat3loxP/loxP:Pax7Cre/+, littermate control: Stat3loxP/loxP:Pax7+/+)
was generated by crossing Stat3loxP/loxP mice with Pax7-Cre mice. The
Stat3/Dmd dKO strain (dKO: Dmd/: Stat3loxP/loxP:Pax7Cre/+, littermate con-
trol: Dmd/: Stat3loxP/loxP:Pax7+/+) was generated by crossing Stat3-cKO
mice withmdx (Dmd/) mice. For all animal-based experiments, at least three
pairs of littermates or age-matched mice were used. Mice with significant
smaller body size were excluded from all experiments. All animal handling
procedures and protocols were approved by the Animal Ethics Committee
at Hong Kong University of Science & Technology (HKUST).
MuSC Sorting by FACS
Mice were sacrificed by cervical dislocation, and hindlimb muscles were
dissected and carefully minced. Muscles were digested with Collagenase II
(800 units/ml) in washing medium (Ham’s F10 with 10% horse serum [HS]) at
37C for 90min. Digestedmuscles were triturated and washed in washing me-
dium before being subjected to further digestion with Collagenase II (80 units/
ml) and Dispase (1 unit/ml) for 30 min. The resulting suspensions were passed
through a 20G needle attached to a syringe 15 times and filtered with a 45-mm
cell strainer. Mononuclear cells were stained with antibodies (Vcam1-biotin,
CD31-fluorescein isothiocyanate [FITC], CD45-FITC, and Sca1-Alxa647).
The Vcam1 signal was amplified with streptavidin-PE-cy7. All antibodies
were used at a dilution of 1:75. The BD FACSAria II cell sorter (BD Biosciences)
was used for MuSC sorting following the manufacturer’s instructions.
Single Myofiber Preparation
Extensor digitorum longus (EDL) muscles were dissected and digested with
Collagenase II (800 units/ml) in washing medium (mentioned above) at 37C
for 75 min. Single myofibers were released by gentle trituration with washing
medium and washed three times in the same medium. Fibers were cultured
in Ham’s F10 medium with either 10% HS for differentiation or 20% fetal
bovine serum (FBS) for proliferation. Fixation was carried out in 2% parafor-
maldehyde at room temperature for 5 min, and immunostaining was conduct-
ed as described below.
RNA-Seq
Total RNA from FACS-sorted MuSCs was extracted with the NucleoSpin RNA
XS kit (Macherey-Nagel). Reverse transcription and cDNA amplification were
done using the SMARTer Ultra Low RNA system (Clontech Laboratories).
Fragmented cDNA was generated by shearing with a Covaris machine fol-
lowed by sequencing library construction with the Ovation Ultralow LibrarySystems (NuGEN Technologies). Pair-end RNA sequencing was done at
BGI. RawRNA sequencing reads weremapped to the reference genome using
Tophat. Transcripts were assembled, and their expression levels were quanti-
fied to identify differentially expressed genes with Cufflinks and Cuffdiff. Raw
data were available at GEO: GSE68736.
Data Analysis
For quantification of staining and qPCR data, unpaired Student’s t test was
used to evaluate the significance of difference between independent sets of
data obtained from mice with different genotypes. Error bars in all figures
represent SEM. The laminin staining and muscle fiber size (i.e., cross-section
area) were analyzed and quantified using MetaMorph Premier Offline software
(7.7.2) provided by the Bioscience Central Research Facility at HKUST.
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